Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.

Authors	C R Alving, E A Steck, W L Hanson, P S Loizeaux, W L Chapman Jr, V B Waits
Journal	Life sciences (Life Sci) Vol. 22 Issue 12 Pg. 1021-6 (Mar 1978) ISSN: 0024-3205 [Print] Netherlands
PMID	642712 (Publication Type: Journal Article)
Chemical References	Liposomes Sorbitol Meglumine
Topics	Animals Cricetinae Leishmaniasis (drug therapy) Liposomes Meglumine (administration & dosage, therapeutic use) Mesocricetus Sorbitol (analogs & derivatives) Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!